Vaxcyte
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,989 | -4,503 | ||
EBITDA | -161,584 | -175,919 | -52,577 | -139,924 |
EBIT | -166,573 | -180,793 | -57,362 | -144,415 |
Net Income | -166,573 | -140,718 | -137,080 | -103,124 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -101,650 | -193,025 | -141,428 | -98,788 |
Cash | 306,744 | 346,850 | 387,878 | 1,050,189 |
Basic Shares | 136,033 | 135,691 | 122,845 | 123,693 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -75,000 | -9,196 | -1,800 | |
EBITDA | -448,082 | -464,885 | -214,289 | -98,277 |
EBIT | -463,927 | -468,041 | -223,485 | -100,077 |
Net Income | -463,927 | -402,266 | -239,640 | -100,084 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -315,905 | |||
Free Cash Flow | -475,054 | -364,667 | -176,445 | -127,948 |
Cash | 387,878 | 397,451 | 834,657 | 68,985 |
Basic Shares | 121,997 | 97,157 | 64,877 | 51,922 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.22 |
2025-03-31 | -$1.04 |
2024-12-31 | -$1.01 |
